Comparison of the incidence and severity of delirium and biochemical factors after coronary artery bypass grafting with dexmedetomidine: A randomized double-blind placebo-controlled clinical trial study.

Abstract

Considering the efficacy of dexmedetomidine on preventing the incidence and severity of delirium and reducing mortality and morbidity, it is recommended that another study with the larger sample size, with different doses and different prescribing methods be conducted to better understand the effect of this drug and achieve a safe dose with maximum efficacy.